Antimicrobial Usage and Resistance in Makkah Region Hospitals: A Regional Point Prevalence Survey of Public Hospitals

Abdul Haseeb, Hani Saleh Faidah, Manal Algethamy, Saleh Alghamdi, Ghaidaa Ali Alhazmi, Afnan Owedah Alshomrani, Bashair Rjyan Alqethami, Hind Saeed Alotibi, Maali Zayed Almutiri, Khawlah Saad Almuqati, Amjad Abdullah Albishi, Mahmoud Essam Elrggal, Ahmad Jamal Mahrous, Asim Abdulaziz Khogeer, Zikria Saleem, Muhammad Shahid Iqbal and Aziz Sheikh
Additional contact information
Abdul Haseeb: Department of Clinical Pharmacy, College of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia
Hani Saleh Faidah: Department of Microbiology, Faculty of Medicine, Umm Al Qura University, Makkah 21955, Saudi Arabia
Manal Algethamy: Department of Infection Prevention and Control Program, Alnoor Specialist Hospital Makkah, Makkah 24382, Saudi Arabia
Saleh Alghamdi: Department of Clinical Pharmacy, Faculty of Clinical Pharmacy, Al Baha University, Al Baha 65779, Saudi Arabia
Ghaidaa Ali Alhazmi: Departments of Pharmacy, King Abdullah Medical City, Ministry of Health, Makkah 21955, Saudi Arabia
Afnan Owedah Alshomrani: King Abdul Aziz Medical City, WR, Jeddah, Ministry of National Guard, Jeddah 21423, Saudi Arabia
Bashair Rjyan Alqethami: Maternity and Children Hospital, Makkah 21955, Saudi Arabia
Hind Saeed Alotibi: Prince Meshari Bin Saud- General Baljarshi Hospital, Al Baha 65779, Saudi Arabia
Maali Zayed Almutiri: Sulaiman AlHabib Medical Group, Jeddah 22230, Saudi Arabia
Khawlah Saad Almuqati: King Faisal Specialist Hospital and Research Centre (Gen. Org.), Riyadh 11211, Saudi Arabia
Amjad Abdullah Albishi: Maternity and Children Hospital, Bishah 24213, Saudi Arabia
Mahmoud Essam Elrggal: Department of Clinical Pharmacy, College of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia
Ahmad Jamal Mahrous: Department of Clinical Pharmacy, College of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia
Asim Abdulaziz Khogeer: Plan and Research Department, General Directorate of Health Affairs of Makkah Region, Ministry of Health, Makkah 21955, Saudi Arabia
Zikria Saleem: Department of Pharmacy Practice, Faculty of Pharmacy, New Campus, The University of Lahore, Lahore 54000, Pakistan
Muhammad Shahid Iqbal: Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia
Aziz Sheikh: Usher Institute, Old Medical School, The University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, UK

IJERPH, 2021, vol. 19, issue 1, 1-8

Abstract: (1) Background: Inappropriate use of antimicrobials and subsequently rise of antimicrobial resistance (AMR) remains a major public health priority. Over-prescribing of broad-spectrum antibiotics is one of the main contributing factors for the emergence of AMR. We sought to describe antimicrobial prescribing trends among patients in public hospitals in Makkah hospitals. (2) Method: We undertook a point prevalence survey (PPS) in six hospitals in Makkah, Saudi Arabia, from January 2019 to July 2019. The survey included all the inpatients receiving antimicrobials on the day of PPS. Data was collected using the Global point prevalence survey (PPS) tool developed by the University of Antwerp, Belgium. (3) Results: Of 710 hospitalized patients, 447 patients (61.9%) were treated with one or more antimicrobials during the study period. The average bed occupancy among six hospitals was 74.4%. The majority of patients received antimicrobials parenterally (90.3%). Of the total prescribed antimicrobials, 415 (53.7%) antimicrobials were used in medical departments, 183 (23.7%) in surgical departments, and 175 (22.6%) in ICUs. Pneumonia (17.3%), skin and soft tissue infections (10.9%), and sepsis (6.6.%) were three common clinical indications. Ceftriaxones were the most commonly used antibiotics that were prescribed in 116 (15%) of patients, followed by piperacillin, with an enzyme inhibitor in 84 (10.9%). (4) Conclusion: There was a high prevalence of antibiotic use in the hospitals of Makkah, which could be a potential risk factor for the incidence of resistant strains, particularly MRSA infection. Public health decision-makers should take these findings into consideration to update national policies for antibiotic use in order to reduce the risks of further increases of AMR.

Keywords: antimicrobial consumption; antimicrobial resistance; point prevalence survey; hospital; Saudi Arabia (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/1/254/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/1/254/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2021:i:1:p:254-:d:711750

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().